Learn How to Prevent OTC Medicine Abuse in Your Community at CADCA’s Mid-Year Training Institute

Jun 9, 2016

Learn strategies to prevent over-the-counter (OTC) medicine abuse in your community, starting with school-aged children, at CADCA’s 15th annual Mid-Year Training Institute at The Mirage Hotel in Las Vegas July 17th-21.

In the “Drugs: Community Kryptonite” track, coalition leaders can take a training session entitled “Teaching Tweens to be Medicine Wise,”on July 18th.
CADCA knows that coalitions often support the implementation of effective programs as part of a comprehensive strategy.

FDA Warns about Serious Heart Problems with High Doses of the Antidiarrheal Medicine Loperamide

Jun 9, 2016

Federal health officials are investigating reports of overdoses and deaths involving widely used anti-diarrhea medicine. The agency has received 31 reports of people hospitalized due to the heart problems, including 10 deaths over the last 39 years.

CADCA Encourages Coalitions to Sign Addiction Change.org Petition

Jun 9, 2016

CADCA's partner The Addiction Policy Forum has launched a change.org petition to urge Congress to quickly conference CARA and

Register for ONDCP Webinar on MAT for Justice Involved Populations

Jun 2, 2016

The Office of National Drug Control Policy (ONDCP) will host a webinar entitled 'Medication Assisted Treatment Programs for Justice Involved Populations' on Tuesday, June 14, from 2-3 p.m. EST.

Leaders Call on Congress to Swiftly Complete Legislation and Provide Essential Funding

The Collaborative for Effective Prescription Opioid Policies (CEPOP) today voiced strong support for bipartisan action this week on multiple bills to address the opioid abuse, misuse, and diversion ravaging communities and families across the nation. 

General Dean Addresses Bi-Partisan Task Force Meeting Today on Capitol Hill

May 12, 2016

CADCA’s Chairman and CEO, Gen. Arthur T. Dean, addressed members of a Bi-Partisan Task Force to Combat the Heroin Epidemic this morning on Capitol Hill.

With the House of Representatives passing 10 opioid bills this week and more votes scheduled for later today, CADCA wanted coalitions to read Gen. Dean’s statement from this morning’s bi-partisan task force meeting.

Here is an excerpt:

Thank you to leaders of the Bi-Partisan Task Force to Combat the Heroin Epidemic for inviting me here today to talk about the critical role of prevention in addressing our nation’s opiate crisis.  

CADCA’s mission is to strengthen the capacity of community coalitions to create and maintain safe, healthy and drug-free communities globally.

We train over 12,000 adult and youth leaders each year on a comprehensive, evidence-based coalition model for community change. 

Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee

Apr 21, 2016

Yesterday, the House Energy & Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug abuse issues affecting communities across the country.

H.R. 3250, The DXM Abuse Prevention Act, authored by Rep. Bill Johnson (R-Ohio) and Rep. Doris Matsui (D-Calif.) is one such piece of legislation. Long supported by CADCA, the bill would restrict the sale of products containing dextromethorphan (DXM) to adults over age 18 nationwide and place restrictions on distribution of bulk DXM.

DEA Announces National Prescription Drug Take-Back Day

Apr 21, 2016

The Drug Enforcement Administration announced the 11th National Prescription Drug Take-Back Day will take place on April 30th from 10 a.m.-2 p.m.

As with the previous nine Take-Back events, sites will be set up nationwide so local residents can return their unwanted or expired prescription drugs for safe disposal. From 2010-2014, DEA officials said more than 2,000 tons of unwanted medication were collected.

Community collection sites can be found by visiting dea.gov. The site will be continuously updated with new take-back locations.

Yesterday, the House Energy & Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug abuse issues affecting communities across the country.

H.R. 3250, The DXM Abuse Prevention Act, authored by Rep. Bill Johnson (R-Ohio) and Rep. Doris Matsui (D-Calif.) is one such piece of legislation. Long supported by CADCA, the bill would restrict the sale of products containing dextromethorphan (DXM) to adults over age 18 nationwide and place restrictions on distribution of bulk DXM.

Pages